Clinical Trial Results

Multiple Sclerosis Implementation Network (Registry)

N/AOBSERVATIONAL Cherry Hill, New Jersey +2 more

RECRUITING

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

PHASE1INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

PHASE3INTERVENTIONAL Palo Alto, California +4 more

RECRUITING

Central Vein Sign in Multiple Sclerosis Extension Study

NAINTERVENTIONAL Los Angeles, California +2 more

RECRUITING

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

PHASE3INTERVENTIONAL Cullman, Alabama +4 more

RECRUITING

Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia

N/AOBSERVATIONAL Lawrenceville, New Jersey

RECRUITING

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

PHASE3INTERVENTIONAL Loma Linda, California +4 more

RECRUITING